With the recent pullback in biotech stocks having created some attractive entry points, here are three “big-time” biotech stocks worth considering right now. CLICK HERE.
While COVID-19 vaccines are grabbing the bulk of the attention, biotech breakthroughs are also being made when it comes to cancer, genetic diseases, neurodegenerative disorders… Read More »7 Biotech Breakthrough Plays (Beyond COVID Vaccines)
With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of… Read More »FDA Approval Of Its Obesity Drug Has This Small Biotech Rocketing Up
If you’re looking for a biotech investment that has been handily beating big biotechs such as Biogen and Gilead Sciences when it comes to returns,… Read More »This Investment Has Been Handily Beating Big Biotechs